|
N.A. Karoli, A.P. Rebrov
Beta-blockers in patients with chronic obstructive pulmonary disease: for whom, when, how?
|
№5 / 2020
|
|
S.B. Fitilev, I.I. Shkrebneva, A.V. Vozzhaev, K.O. Tsukanova, D.A. Dimitrovа
TRENDS IN THE USE OF ANTI-ANGINAL PREPARATIONS IN THE SPECIALIZED OUTPATIENT CLINIC FOR THE FIVE-YEAR PERIOD
|
№15 / 2017
|
|
M.Yu. Ogarkov (1), Yu. V. Kovaleva (1), T.A. Mulerova (2)
BISOPROLOL IN THE TREATMENT OF CHRONIC HEART FAILURE
|
№13 / 2016
|
|
S.V. Shalaev (1, 2), L.V. Kremneva (3), O.V. Abaturova (1)
NEBIVOLOL IN THE TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE
|
№13 / 2015
|
|
V.S. Nikiforov
BLOOD VISCOSITY AS A TARGET OF THERAPEUTIC INTERVENTION IN CARDIOVASCULAR PATHOLOGY
|
№13 / 2015
|
|
E.V. Privalova
MODERN LOOK AT ANTIANGINAL THERAPY OF PATIENTS WITH CORONARY ARTERY DISEASE
|
№13 / 2015
|
|
A.A. Kirichenko
BISOPROLOL AND CHRONIC HEART FAILURE
|
№9 / 2014
|
|
E.N. Basargina, E.N. Arkhipova, O.P. Zharova
WIDESPREAD MISTAKES IN THE TREATMENT OF CHRONIC HEART FAILURE WITH REDUCED LEFT-VENTRICULAR SYSTOLIC FUNCTION IN CHILDREN
|
№1 / 2014
|
|
M.G. Gleser (1, 2), E.I. Astashkin (1), M.V. Novikova (2)
TREATMENT OF STABLE ANGINA: CURRENT STATE OF PROBLEM
|
№18 / 2013
|
Русский
